Cornelis J.A. Haasbeek

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.9K citations

Medicine, Oncology, Radiation Oncology +15

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Joe Y. Chang, Suresh Senan, Marinus A. Paul et al. · The Lancet Oncology · 2015 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +8

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer

Frank J. Lagerwaard, Cornelis J.A. Haasbeek, Egbert F. Smit et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 535 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis

Sashendra Senthi, Frank J. Lagerwaard, Cornelis J.A. Haasbeek et al. · The Lancet Oncology · 2012 · 445 citations

Medicine, Oncology, Radiation Oncology +13